Banerjee Ena Ray, Jiang Yi, Henderson William R, Latchman Yvette, Papayannopoulou Thalia
Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA 98195-7710, USA.
Exp Hematol. 2009 Jun;37(6):715-727.e3. doi: 10.1016/j.exphem.2009.03.010.
Chronic asthma is characterized by ongoing recruitment of inflammatory cells and airway hyperresponsiveness leading to structural airway remodeling. Although alpha 4 beta 1 and beta2 integrins regulate leukocyte migration in inflammatory diseases and play decisive roles in acute asthma, their role has not been explored under the chronic asthma setting. To extend our earlier studies with alpha 4(Delta/Delta) and beta2(-/-) mice, which showed that both alpha 4 and beta2 integrins have nonredundant regulatory roles in acute ovalbumin (OVA)-induced asthma, we explored to what extent these molecular pathways control development of structural airway remodeling in chronic asthma.
Control, alpha 4(Delta/Delta), and beta2(-/-) mouse groups, sensitized by intraperitoneal OVA as allergen, received intratracheal OVA periodically over days 8 to 55 to induce a chronic asthma phenotype. Post-OVA assessment of inflammation and pulmonary function (airway hyperresponsiveness), together with airway modeling measured by goblet cell metaplasia, collagen content of lung, and transforming growth factor beta1 expression in lung homogenates, were evaluated.
In contrast to control and beta2(-/-) mice, alpha 4(Delta/Delta) mice failed to develop and maintain the composite chronic asthma phenotype evaluated as mentioned and subepithelial collagen content was comparable to baseline. These data indicate that beta2 integrins, although required for inflammatory migration in acute asthma, are dispensable for structural remodeling in chronic asthma.
alpha 4 integrins appear to have a regulatory role in directing transforming growth factor beta-induced collagen deposition and structural alterations in lung architecture likely through interactions of Th2 cells, eosinophils, or mast cells with endothelium, resident airway cells, and/or extracellular matrix.
慢性哮喘的特征是炎症细胞持续募集和气道高反应性,导致气道结构重塑。虽然α4β1和β2整合素在炎症性疾病中调节白细胞迁移并在急性哮喘中起决定性作用,但它们在慢性哮喘环境中的作用尚未得到探索。为了扩展我们早期对α4(Δ/Δ)和β2(-/-)小鼠的研究,这些研究表明α4和β2整合素在急性卵清蛋白(OVA)诱导的哮喘中具有非冗余的调节作用,我们探讨了这些分子途径在多大程度上控制慢性哮喘中气道结构重塑的发展。
通过腹腔注射OVA作为变应原致敏的对照、α4(Δ/Δ)和β2(-/-)小鼠组,在第8至55天期间定期接受气管内OVA注射以诱导慢性哮喘表型。评估OVA后炎症和肺功能(气道高反应性),以及通过杯状细胞化生、肺胶原蛋白含量和肺匀浆中转化生长因子β1表达测量的气道重塑。
与对照和β2(-/-)小鼠相比,α4(Δ/Δ)小鼠未能发展和维持上述评估的复合慢性哮喘表型,并且上皮下胶原蛋白含量与基线相当。这些数据表明,β2整合素虽然在急性哮喘的炎症迁移中是必需的,但在慢性哮喘的结构重塑中是可有可无的。
α4整合素似乎在指导转化生长因子β诱导的胶原蛋白沉积和肺结构改变中具有调节作用,可能是通过Th2细胞、嗜酸性粒细胞或肥大细胞与内皮细胞、驻留气道细胞和/或细胞外基质的相互作用。